01
Immunotherapy multi-omics cohort
A planned 2,000-patient cohort centered on metagenomics and metabolomics to study immune therapy response, resistance, toxicity, and host-microbiome-metabolism interactions.
- Scientific questions: Which microbiome-metabolite patterns predict immunotherapy benefit or toxicity? Can microbial functions explain primary resistance and acquired resistance? Which signals are stable enough for prospective stratification?
02
Pathology and imaging cohorts
Multi-cancer pathology and imaging cohorts designed to connect tissue morphology, radiological phenotypes, clinical outcomes, and computational oncology models.
- Scientific questions: Can pathology and radiology jointly identify immune-hot or immune-cold tumors? Which visual features predict recurrence, metastasis, response, and drug resistance? How can image models remain explainable in clinical oncology?
03
Pan-cancer single-cell and spatial cohorts
Self-generated pan-cancer single-cell and spatial transcriptomics cohorts, expected to reach 1,000+ and 300+ patients respectively, for immune ecology and spatial mechanism studies.
- Scientific questions: Which cell states drive immune escape and metastasis across cancers? How do CAFs, macrophages, T cells, and tumor cells organize spatial niches? Which spatial programs can become drug targets or companion diagnostics?
Faculty members and clinical researchers interested in these cohorts are warmly welcome to contact us for collaboration.
Email the lab